Global Veterinary Biologics Market Growth 2021-2026

  • receipt Report ID : 276909
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 167
  • list Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Veterinary Biologics will have significant change from previous year. By the most conservative estimates of global Veterinary Biologics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Veterinary Biologics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Biologics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Vaccines

Monoclonal Antibodies

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Llivestock

Equine

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Merck

Zoetis

Boehringer Ingelheim

Ceva

CAHIC

HVRI

Ringpu Biology

Yebio

DHN

WINSUN

Elanco/Eli Lilly

Virbac

Jinyu Bio-Technology

ChengDu Tecbond

CAVAC

Kyoto Biken

FATRO

Vaksindo

Bio-Labs

Avimex Animal

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Veterinary Biologics Consumption 2016-2026

2.1.2 Veterinary Biologics Consumption CAGR by Region

2.2 Veterinary Biologics Segment by Type

2.2.1 Vaccines

2.2.2 Monoclonal Antibodies

2.3 Veterinary Biologics Sales by Type

2.3.1 Global Veterinary Biologics Sales Market Share by Type (2016-2021)

2.3.2 Global Veterinary Biologics Revenue and Market Share by Type (2016-2021)

2.3.3 Global Veterinary Biologics Sale Price by Type (2016-2021)

2.4 Veterinary Biologics Segment by Application

2.4.1 Llivestock

2.4.2 Equine

2.4.3 Other

2.5 Veterinary Biologics Sales by Application

2.5.1 Global Veterinary Biologics Sale Market Share by Application (2016-2021)

2.5.2 Global Veterinary Biologics Revenue and Market Share by Application (2016-2021)

2.5.3 Global Veterinary Biologics Sale Price by Application (2016-2021)

3 Global Veterinary Biologics by Company

3.1 Global Veterinary Biologics Sales Market Share by Company

3.1.1 Global Veterinary Biologics Sales by Company (2019-2021)

3.1.2 Global Veterinary Biologics Sales Market Share by Company (2019-2021)

3.2 Global Veterinary Biologics Revenue Market Share by Company

3.2.1 Global Veterinary Biologics Revenue by Company (2019-2021)

3.2.2 Global Veterinary Biologics Revenue Market Share by Company (2019-2021)

3.3 Global Veterinary Biologics Sale Price by Company

3.4 Global Manufacturers Veterinary Biologics Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Veterinary Biologics Product Location Distribution

3.4.2 Players Veterinary Biologics Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Veterinary Biologics by Region

4.1 Global Veterinary Biologics by Region

4.1.1 Global Veterinary Biologics Sales by Region

4.1.2 Global Veterinary Biologics Revenue by Region

4.2 Americas Veterinary Biologics Sales Growth

4.3 APAC Veterinary Biologics Sales Growth

4.4 Europe Veterinary Biologics Sales Growth

4.5 Middle East & Africa Veterinary Biologics Sales Growth

5 Americas

5.1 Americas Veterinary Biologics Sales by Country

5.1.1 Americas Veterinary Biologics Sales by Country (2016-2021)

5.1.2 Americas Veterinary Biologics Revenue by Country (2016-2021)

5.2 Americas Veterinary Biologics Sales by Type

5.3 Americas Veterinary Biologics Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Veterinary Biologics Sales by Region

6.1.1 APAC Veterinary Biologics Sales by Region (2016-2021)

6.1.2 APAC Veterinary Biologics Revenue by Region (2016-2021)

6.2 APAC Veterinary Biologics Sales by Type

6.3 APAC Veterinary Biologics Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Veterinary Biologics by Country

7.1.1 Europe Veterinary Biologics Sales by Country (2016-2021)

7.1.2 Europe Veterinary Biologics Revenue by Country (2016-2021)

7.2 Europe Veterinary Biologics Sales by Type

7.3 Europe Veterinary Biologics Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Veterinary Biologics by Country

8.1.1 Middle East & Africa Veterinary Biologics Sales by Country (2016-2021)

8.1.2 Middle East & Africa Veterinary Biologics Revenue by Country (2016-2021)

8.2 Middle East & Africa Veterinary Biologics Sales by Type

8.3 Middle East & Africa Veterinary Biologics Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Veterinary Biologics Distributors

10.3 Veterinary Biologics Customer

11 Global Veterinary Biologics Market Forecast

11.1 Global Veterinary Biologics Forecast by Region

11.1.1 Global Veterinary Biologics Forecast by Regions (2021-2026)

11.2.2 Global Veterinary Biologics Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Veterinary Biologics Forecast by Type

11.7 Global Veterinary Biologics Forecast by Application

12 Key Players Analysis

12.1 Merck

12.1.1 Merck Company Information

12.1.2 Merck Veterinary Biologics Product Offered

12.1.3 Merck Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Merck Main Business Overview

12.1.5 Merck Latest Developments

12.2 Zoetis

12.2.1 Zoetis Company Information

12.2.2 Zoetis Veterinary Biologics Product Offered

12.2.3 Zoetis Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Zoetis Main Business Overview

12.2.5 Zoetis Latest Developments

12.3 Boehringer Ingelheim

12.3.1 Boehringer Ingelheim Company Information

12.3.2 Boehringer Ingelheim Veterinary Biologics Product Offered

12.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Boehringer Ingelheim Main Business Overview

12.3.5 Boehringer Ingelheim Latest Developments

12.4 Ceva

12.4.1 Ceva Company Information

12.4.2 Ceva Veterinary Biologics Product Offered

12.4.3 Ceva Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Ceva Main Business Overview

12.4.5 Ceva Latest Developments

12.5 CAHIC

12.5.1 CAHIC Company Information

12.5.2 CAHIC Veterinary Biologics Product Offered

12.5.3 CAHIC Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 CAHIC Main Business Overview

12.5.5 CAHIC Latest Developments

12.6 HVRI

12.6.1 HVRI Company Information

12.6.2 HVRI Veterinary Biologics Product Offered

12.6.3 HVRI Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 HVRI Main Business Overview

12.6.5 HVRI Latest Developments

12.7 Ringpu Biology

12.7.1 Ringpu Biology Company Information

12.7.2 Ringpu Biology Veterinary Biologics Product Offered

12.7.3 Ringpu Biology Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Ringpu Biology Main Business Overview

12.7.5 Ringpu Biology Latest Developments

12.8 Yebio

12.8.1 Yebio Company Information

12.8.2 Yebio Veterinary Biologics Product Offered

12.8.3 Yebio Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Yebio Main Business Overview

12.8.5 Yebio Latest Developments

12.9 DHN

12.9.1 DHN Company Information

12.9.2 DHN Veterinary Biologics Product Offered

12.9.3 DHN Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 DHN Main Business Overview

12.9.5 DHN Latest Developments

12.10 WINSUN

12.10.1 WINSUN Company Information

12.10.2 WINSUN Veterinary Biologics Product Offered

12.10.3 WINSUN Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 WINSUN Main Business Overview

12.10.5 WINSUN Latest Developments

12.11 Elanco/Eli Lilly

12.11.1 Elanco/Eli Lilly Company Information

12.11.2 Elanco/Eli Lilly Veterinary Biologics Product Offered

12.11.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Elanco/Eli Lilly Main Business Overview

12.11.5 Elanco/Eli Lilly Latest Developments

12.12 Virbac

12.12.1 Virbac Company Information

12.12.2 Virbac Veterinary Biologics Product Offered

12.12.3 Virbac Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Virbac Main Business Overview

12.12.5 Virbac Latest Developments

12.13 Jinyu Bio-Technology

12.13.1 Jinyu Bio-Technology Company Information

12.13.2 Jinyu Bio-Technology Veterinary Biologics Product Offered

12.13.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Jinyu Bio-Technology Main Business Overview

12.13.5 Jinyu Bio-Technology Latest Developments

12.14 ChengDu Tecbond

12.14.1 ChengDu Tecbond Company Information

12.14.2 ChengDu Tecbond Veterinary Biologics Product Offered

12.14.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 ChengDu Tecbond Main Business Overview

12.14.5 ChengDu Tecbond Latest Developments

12.15 CAVAC

12.15.1 CAVAC Company Information

12.15.2 CAVAC Veterinary Biologics Product Offered

12.15.3 CAVAC Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 CAVAC Main Business Overview

12.15.5 CAVAC Latest Developments

12.16 Kyoto Biken

12.16.1 Kyoto Biken Company Information

12.16.2 Kyoto Biken Veterinary Biologics Product Offered

12.16.3 Kyoto Biken Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Kyoto Biken Main Business Overview

12.16.5 Kyoto Biken Latest Developments

12.17 FATRO

12.17.1 FATRO Company Information

12.17.2 FATRO Veterinary Biologics Product Offered

12.17.3 FATRO Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 FATRO Main Business Overview

12.17.5 FATRO Latest Developments

12.18 Vaksindo

12.18.1 Vaksindo Company Information

12.18.2 Vaksindo Veterinary Biologics Product Offered

12.18.3 Vaksindo Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.18.4 Vaksindo Main Business Overview

12.18.5 Vaksindo Latest Developments

12.19 Bio-Labs

12.19.1 Bio-Labs Company Information

12.19.2 Bio-Labs Veterinary Biologics Product Offered

12.19.3 Bio-Labs Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.19.4 Bio-Labs Main Business Overview

12.19.5 Bio-Labs Latest Developments

12.20 Avimex Animal

12.20.1 Avimex Animal Company Information

12.20.2 Avimex Animal Veterinary Biologics Product Offered

12.20.3 Avimex Animal Veterinary Biologics Sales, Revenue, Price and Gross Margin (2019-2021)

12.20.4 Avimex Animal Main Business Overview

12.20.5 Avimex Animal Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Veterinary Biologics Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Vaccines

Table 3. Major Players of Monoclonal Antibodies

Table 4. Global Veterinary Biologics Sales by Type (2016-2021) & (K Units)

Table 5. Global Veterinary Biologics Sales Market Share by Type (2016-2021)

Table 6. Global Veterinary Biologics Revenue by Type (2016-2021) & ($ million)

Table 7. Global Veterinary Biologics Revenue Market Share by Type (2016-2021)

Table 8. Global Veterinary Biologics Sale Price by Type (2016-2021)

Table 9. Global Veterinary Biologics Sales by Application (2016-2021) & (K Units)

Table 10. Global Veterinary Biologics Sales Market Share by Application (2016-2021)

Table 11. Global Veterinary Biologics Value by Application (2016-2021)

Table 12. Global Veterinary Biologics Revenue Market Share by Application (2016-2021)

Table 13. Global Veterinary Biologics Sale Price by Application (2016-2021)

Table 14. Global Veterinary Biologics Sales by Company (2019-2021) & (K Units)

Table 15. Global Veterinary Biologics Sales Market Share by Company (2019-2021)

Table 16. Global Veterinary Biologics Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Veterinary Biologics Revenue Market Share by Company (2019-2021)

Table 18. Global Veterinary Biologics Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Veterinary Biologics Producing Area Distribution and Sales Area

Table 20. Players Veterinary Biologics Products Offered

Table 21. Veterinary Biologics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Veterinary Biologics Sales by Region (2016-2021) (K Units)

Table 25. Global Veterinary Biologics Sales Market Share by Region (2016-2021)

Table 26. Global Veterinary Biologics Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Veterinary Biologics Revenue Market Share by Region (2016-2021)

Table 28. Americas Veterinary Biologics Sales by Country (2016-2021) & (K Units)

Table 29. Americas Veterinary Biologics Sales Market Share by Country (2016-2021)

Table 30. Americas Veterinary Biologics Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Veterinary Biologics Revenue Market Share by Country (2016-2021)

Table 32. Americas Veterinary Biologics Sales by Type (2016-2021) & (K Units)

Table 33. Americas Veterinary Biologics Sales Market Share by Type (2016-2021)

Table 34. Americas Veterinary Biologics Sales by Application (2016-2021) & (K Units)

Table 35. Americas Veterinary Biologics Sales Market Share by Application (2016-2021)

Table 36. APAC Veterinary Biologics Sales by Region (2016-2021) & (K Units)

Table 37. APAC Veterinary Biologics Sales Market Share by Region (2016-2021)

Table 38. APAC Veterinary Biologics Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Veterinary Biologics Revenue Market Share by Region (2016-2021)

Table 40. APAC Veterinary Biologics Sales by Type (2016-2021) & (K Units)

Table 41. APAC Veterinary Biologics Sales Market Share by Type (2016-2021)

Table 42. APAC Veterinary Biologics Sales by Application (2016-2021) & (K Units)

Table 43. APAC Veterinary Biologics Sales Market Share by Application (2016-2021)

Table 44. Europe Veterinary Biologics Sales by Country (2016-2021) & (K Units)

Table 45. Europe Veterinary Biologics Sales Market Share by Country (2016-2021)

Table 46. Europe Veterinary Biologics Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Veterinary Biologics Revenue Market Share by Country (2016-2021)

Table 48. Europe Veterinary Biologics Sales by Type (2016-2021) & (K Units)

Table 49. Europe Veterinary Biologics Sales Market Share by Type (2016-2021)

Table 50. Europe Veterinary Biologics Sales by Application (2016-2021) & (K Units)

Table 51. Europe Veterinary Biologics Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Veterinary Biologics Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa Veterinary Biologics Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Veterinary Biologics Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Veterinary Biologics Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Veterinary Biologics Sales by Type (2016-2021) & (K Units)

Table 57. Middle East & Africa Veterinary Biologics Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Veterinary Biologics Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa Veterinary Biologics Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Veterinary Biologics

Table 61. Key Application and Potential Industries of Veterinary Biologics

Table 62. Key Challenges of Veterinary Biologics

Table 63. Key Trends of Veterinary Biologics

Table 64. Veterinary Biologics Distributors List

Table 65. Veterinary Biologics Customer List

Table 66. Global Veterinary Biologics Sales Forecast by Region (2021-2026) & (K Units)

Table 67. Global Veterinary Biologics Consumption Market Forecast by Region

Table 68. Global Veterinary Biologics Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Veterinary Biologics Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Veterinary Biologics Sales Forecast by Country (2021-2026) & (K Units)

Table 71. Americas Veterinary Biologics Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Veterinary Biologics Sales Forecast by Region (2021-2026) & (K Units)

Table 73. APAC Veterinary Biologics Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Veterinary Biologics Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Europe Veterinary Biologics Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Veterinary Biologics Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Middle East & Africa Veterinary Biologics Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Veterinary Biologics Sales Forecast by Type (2021-2026) & (K Units)

Table 79. Global Veterinary Biologics Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Veterinary Biologics Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Veterinary Biologics Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Veterinary Biologics Sales Forecast by Application (2021-2026) & (K Units)

Table 83. Global Veterinary Biologics Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Veterinary Biologics Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Veterinary Biologics Revenue Market Share Forecast by Application (2021-2026)

Table 86. Merck Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 87. Merck Veterinary Biologics Product Offered

Table 88. Merck Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 89. Merck Main Business

Table 90. Merck Latest Developments

Table 91. Zoetis Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 92. Zoetis Veterinary Biologics Product Offered

Table 93. Zoetis Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 94. Zoetis Main Business

Table 95. Zoetis Latest Developments

Table 96. Boehringer Ingelheim Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 97. Boehringer Ingelheim Veterinary Biologics Product Offered

Table 98. Boehringer Ingelheim Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 99. Boehringer Ingelheim Main Business

Table 100. Boehringer Ingelheim Latest Developments

Table 101. Ceva Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 102. Ceva Veterinary Biologics Product Offered

Table 103. Ceva Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 104. Ceva Main Business

Table 105. Ceva Latest Developments

Table 106. CAHIC Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 107. CAHIC Veterinary Biologics Product Offered

Table 108. CAHIC Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 109. CAHIC Main Business

Table 110. CAHIC Latest Developments

Table 111. HVRI Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 112. HVRI Veterinary Biologics Product Offered

Table 113. HVRI Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 114. HVRI Main Business

Table 115. HVRI Latest Developments

Table 116. Ringpu Biology Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 117. Ringpu Biology Veterinary Biologics Product Offered

Table 118. Ringpu Biology Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 119. Ringpu Biology Main Business

Table 120. Ringpu Biology Latest Developments

Table 121. Yebio Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 122. Yebio Veterinary Biologics Product Offered

Table 123. Yebio Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 124. Yebio Main Business

Table 125. Yebio Latest Developments

Table 126. DHN Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 127. DHN Veterinary Biologics Product Offered

Table 128. DHN Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 129. DHN Main Business

Table 130. DHN Latest Developments

Table 131. WINSUN Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 132. WINSUN Veterinary Biologics Product Offered

Table 133. WINSUN Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 134. WINSUN Main Business

Table 135. WINSUN Latest Developments

Table 136. Elanco/Eli Lilly Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 137. Elanco/Eli Lilly Veterinary Biologics Product Offered

Table 138. Elanco/Eli Lilly Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 139. Elanco/Eli Lilly Main Business

Table 140. Elanco/Eli Lilly Latest Developments

Table 141. Virbac Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 142. Virbac Veterinary Biologics Product Offered

Table 143. Virbac Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 144. Virbac Main Business

Table 145. Virbac Latest Developments

Table 146. Jinyu Bio-Technology Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 147. Jinyu Bio-Technology Veterinary Biologics Product Offered

Table 148. Jinyu Bio-Technology Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 149. Jinyu Bio-Technology Main Business

Table 150. Jinyu Bio-Technology Latest Developments

Table 151. ChengDu Tecbond Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 152. ChengDu Tecbond Veterinary Biologics Product Offered

Table 153. ChengDu Tecbond Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 154. ChengDu Tecbond Main Business

Table 155. ChengDu Tecbond Latest Developments

Table 156. CAVAC Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 157. CAVAC Veterinary Biologics Product Offered

Table 158. CAVAC Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 159. CAVAC Main Business

Table 160. CAVAC Latest Developments

Table 161. Kyoto Biken Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 162. Kyoto Biken Veterinary Biologics Product Offered

Table 163. Kyoto Biken Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 164. Kyoto Biken Main Business

Table 165. Kyoto Biken Latest Developments

Table 166. FATRO Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 167. FATRO Veterinary Biologics Product Offered

Table 168. FATRO Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 169. FATRO Main Business

Table 170. FATRO Latest Developments

Table 171. Vaksindo Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 172. Vaksindo Veterinary Biologics Product Offered

Table 173. Vaksindo Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 174. Vaksindo Main Business

Table 175. Vaksindo Latest Developments

Table 176. Bio-Labs Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 177. Bio-Labs Veterinary Biologics Product Offered

Table 178. Bio-Labs Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 179. Bio-Labs Main Business

Table 180. Bio-Labs Latest Developments

Table 181. Avimex Animal Basic Information, Veterinary Biologics Manufacturing Base, Sales Area and Its Competitors

Table 182. Avimex Animal Veterinary Biologics Product Offered

Table 183. Avimex Animal Veterinary Biologics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 184. Avimex Animal Main Business

Table 185. Avimex Animal Latest Developments

List of Figures

Figure 1. Picture of Veterinary Biologics

Figure 2. Veterinary Biologics Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Veterinary Biologics Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Veterinary Biologics Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Veterinary Biologics Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Vaccines

Figure 10. Product Picture of Monoclonal Antibodies

Figure 11. Global Veterinary Biologics Sales Market Share by Type in 2020

Figure 12. Global Veterinary Biologics Revenue Market Share by Type (2016-2021)

Figure 13. Veterinary Biologics Consumed in Llivestock

Figure 14. Global Veterinary Biologics Market: Llivestock (2016-2021) & (K Units)

Figure 15. Veterinary Biologics Consumed in Equine

Figure 16. Global Veterinary Biologics Market: Equine (2016-2021) & (K Units)

Figure 17. Veterinary Biologics Consumed in Other

Figure 18. Global Veterinary Biologics Market: Other (2016-2021) & (K Units)

Figure 19. Global Veterinary Biologics Sales Market Share by Application (2016-2021)

Figure 20. Global Veterinary Biologics Revenue Market Share by Application in 2020

Figure 21. Veterinary Biologics Revenue Market by Company in 2020 ($ Million)

Figure 22. Global Veterinary Biologics Revenue Market Share by Company in 2020

Figure 23. Global Veterinary Biologics Sales Market Share by Regions (2016-2021)

Figure 24. Global Veterinary Biologics Revenue Market Share by Region in 2020

Figure 25. Americas Veterinary Biologics Sales 2016-2021 (K Units)

Figure 26. Americas Veterinary Biologics Revenue 2016-2021 ($ Millions)

Figure 27. APAC Veterinary Biologics Sales 2016-2021 (K Units)

Figure 28. APAC Veterinary Biologics Revenue 2016-2021 ($ Millions)

Figure 29. Europe Veterinary Biologics Sales 2016-2021 (K Units)

Figure 30. Europe Veterinary Biologics Revenue 2016-2021 ($ Millions)

Figure 31. Middle East & Africa Veterinary Biologics Sales 2016-2021 (K Units)

Figure 32. Middle East & Africa Veterinary Biologics Revenue 2016-2021 ($ Millions)

Figure 33. Americas Veterinary Biologics Sales Market Share by Country in 2020

Figure 34. Americas Veterinary Biologics Revenue Market Share by Country in 2020

Figure 35. Americas Veterinary Biologics Sales Market Share by Type in 2020

Figure 36. Americas Veterinary Biologics Sales Market Share by Application in 2020

Figure 37. United States Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 38. Canada Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 39. Mexico Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 40. Brazil Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 41. APAC Veterinary Biologics Sales Market Share by Region in 2020

Figure 42. APAC Veterinary Biologics Revenue Market Share by Regions in 2020

Figure 43. APAC Veterinary Biologics Sales Market Share by Type in 2020

Figure 44. APAC Veterinary Biologics Sales Market Share by Application in 2020

Figure 45. China Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 46. Japan Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 47. Korea Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 48. Southeast Asia Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 49. India Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 50. Australia Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 51. Europe Veterinary Biologics Sales Market Share by Country in 2020

Figure 52. Europe Veterinary Biologics Revenue Market Share by Country in 2020

Figure 53. Europe Veterinary Biologics Sales Market Share by Type in 2020

Figure 54. Europe Veterinary Biologics Sales Market Share by Application in 2020

Figure 55. Germany Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 56. France Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 57. UK Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 58. Italy Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 59. Russia Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 60. Middle East & Africa Veterinary Biologics Sales Market Share by Country in 2020

Figure 61. Middle East & Africa Veterinary Biologics Revenue Market Share by Country in 2020

Figure 62. Middle East & Africa Veterinary Biologics Sales Market Share by Type in 2020

Figure 63. Middle East & Africa Veterinary Biologics Sales Market Share by Application in 2020

Figure 64. Egypt Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 65. South Africa Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 66. Israel Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 67. Turkey Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 68. GCC Country Veterinary Biologics Revenue Growth 2016-2021 ($ Millions)

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

Please fill the form below, to recieve the report sample


+1